This review highlights the pharmacological potential of Argyreia species, including key phytochemical constituents, suggesting new therapeutic avenues.
The genus Argyreia (Family Convolvulaceae), consists of about 28 species spread throughout Asia and Africa, and is of considerable ethnomedicinal significance. These plants have been traditionally used to manage a range of diseases, including metabolic disorders, infections, neurological disorders, and inflammatory conditions. Of these, Argyreia nervosa and Argyreia speciosa are the most widely investigated for various pharmacological activities like central nervous system activity, aphrodisiac activity, antioxidant activity, etc. Phytochemical investigations reveal the presence of diverse bioactive constituents, including ergoline alkaloids, flavonoids, terpenoids, glycosides, saponins, and coumarins, most of which are responsible for the noted pharmacological effects. Seeds of Argyreia speciosa are reported to possess Lysergic Acid Amide (LSA), a psychotropic compound possessing CNS depressant and anxiolytic activity. Roots and leaf extracts of various species of Argyreia have been found to possess hepatoprotective, anti-inflammatory, and antimicrobial activity. The biological activities of the least explored species of Argyreia, such as A. acanthocarpa, A. hirsuta, and A. cymosa, possess antidiabetic, analgesic, and wound-healing activities, respectively, which need to be scientifically validated for their therapeutic potential. Even with traditional assertions and preclinical justifications, clinical evidence regarding Argyreia species is limited. Heterogeneity in preparation techniques, absence of standardized phytochemical profiling, and limited toxicity tests discourage translational purposes. However, new pharmacological data indicate robust therapeutic potential to be pursued. This review integrates ethnobotanical information, phytochemical observations, and pharmacological assessments to point to the therapeutic potential of Argyreia. The genus presents an interesting case for clinical investigation, compound isolation, and pharmacodynamic analysis to generate safe and effective herbal remedies. Scientific validation would close the gap between traditional medicine and novel drug discovery, broadening the repertoire of plant-derived therapeutic agents.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2025) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: